New analysis suggests emergency department blood-borne virus testing could be cost-effective in Poland
New modelling presented at EASL Congress 2026 suggests that emergency department opt-out testing for HIV, hepatitis B (HBV) and hepatitis C (HCV) in Poland could improve diagnosis and linkage to care, while remaining cost-effective over a lifetime horizon. The study assessed the clinical and economic impact of introducing emergency department blood-borne virus (BBV) opt-out testing Read More >